Watch for Patients Getting OTC Primatene Mist for Asthma

January 2019

You may be surprised to see Primatene Mist (epinephrine) on patients' home med lists.

It was withdrawn in 2011 due to chlorofluorocarbon (CFC) propellant regulations, NOT safety issues. But many were happy to see it go.

Now Primatene Mist is back with an HFA propellant.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Operations & Management Take Steps to Maximize Benefits but Minimize Problems With Consignment Meds
Hazardous Meds Prevent Unnecessary Exposure to Hazardous Meds
Iron Know How IV Iron Products Compare
Medication Errors Use Strategies to Stop Mix-Ups Between Lamotrigine and Labetalol
Antibiotics Keep an Eye Out for the New Tetracycline Antibiotic Nuzyra
Antiarrhythmics Keep Patients Getting Amiodarone Safe
Liver Disease Be Familiar With Special Needs of Cirrhosis Patients Going to Surgery
Cholesterol Anticipate More Patients Getting Vascepa to Help Reduce Heart Events
Asthma Watch for Patients Getting OTC Primatene Mist for Asthma
MRSA Don't Automatically Substitute Generic Mupirocin for Bactroban Nasal